|
|
|
|
红景天提取物Rhodiola Rosea Extract
| |
|
红景天提取物
产品名称: 红景天提取物
拉丁名: Rhodiola Rosea
CAS号.: 10338-51-9
有效成分:红景天甙,洛塞维
规格: 1% 2% 3%
检测方式: HPLC
外观: 棕褐色粉末
红景天提取物是红景天根部的提取物,气香甜、味苦涩。主要成份为红景天苷和甙元酪醇、络塞维,具有增强免疫功能、保护心脑血管及 抗抑郁的功效。
红景天提取物
植物来源:本产品为景天科植物红景天(Rhodiola rosea L.)的干燥根茎。
外观:淡黄色或棕红色粉末
有效成分:红景天甙,罗塞维
规格:红景天甙1%-10%,罗塞维1%-10%
检测方法:HPLC
CAS 编号:红景天甙 10338-51-9 ,罗塞维84954-92-7
分子式:红景天甙 C14H20O7 , 罗塞维C20H28O10
分子量:红景天甙300.304 , 罗塞维428.4303
红景天甙罗塞维
包装:25公斤/桶
储存:阴凉干燥处存放
保质期:2年
用途:具有提高机体免疫力,增强体质,改善人体造血机能,抗缺氧,抗衰老,抗肿瘤,抗疲劳,降血糖,抗病毒,抗放射,预防高原反应等多种功能。
产品详询:13657416805
References:
- 1.Perfumi M., Mahioli L., Adaptogenic and CNS effects on single dose of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice, Phytother Res, 2007, 21, 37–43
- 2.Qu ZQ., Zhou Y., Zeng YS., Li Y., Cheng Pl., Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebrovascular streptozotocin in rats: implication of anti-oxidative and neuroprotective effects, Biomedical and Enviromental Science, 2009, 22, 318–326
- 3.Panossian A., Wilkman G., Sarris J., Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy, Phytomedicine, 2010, 7, 481–493
- 4.Elamen A., Dragland S., Klemsdal SS., Bioactive compounds produced by clones of Rhodiola rosea maintained in the Norwegian germplasm collection, Pharmazie, 2010, 65, 618–23
- 5.Staneva J., Todorova M., Neykov N., Evstatieva L,. Ultrasonically assisted extraction of total phenols and flavonoids from Rhodiola rosea, Natural Product Communications, 2009, 4, 935–938
- 6.Khakpai F., Nasehi M., Haeri-Rohani A., Eidi A., Zarrindast MR., Scopolamine induced memory impairment; possible involvement of NMDA receptors mechanisms of dorsal hippocampus and/or septum, Behavioral Brain Research, 2012, 231, 1–10
- 7.Park SJ., Kim DH., Jung JM., Kim JM., Cai M., Liu X., et al, The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice, Europian Journal of Pharmacology, 2012, 676, 64–70
- 8.Knox LT., Jing Y., Fleete MS., Collie VD., Zhang H., Liu P., Scopolamine impairs behavioral function and arginine metabolism in the rat dentate gyrus, Neuropharmacology, 2011, 61, 1452–1462
- 9.Klinkenberg I., Blokland A., A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment, Psychopharmacology (Berl), 2011, 15, 549–566
- 10.Evstatieva L., Todorova M., Antonova D., Quality control of extracts of Rhodiola rosea L. based on the content of salidroside and rosavines, Proc, 5 CMAPSEEC, 2011, 208, 2–5
- 11.Evstatieva L., Todorova M., Antonova D., Staneva J., Chemical composition of the essential oils of Rhodiola rosea L. of three different origins, Pharmacognosy Mag, 2010, 6, 256–258
- 12.Kesner RP., Churchwell JC., An Analysis of rat prefrontal cortex in mediating executive functions, Neurobiol, Learn, Memory, 2011, 96, 417–31
- 13.Shi TY., Feng SF., Xing JH., WU JM., Li XQ., Zhang N., et al, Neuroprotective effects of salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and h(2)o (2)-induced neurotoxicity in vitro, Neurotox Res, 2012, 21, 358–367
- 14.Tulsawani B., Meena DK., Shukla H., Sharma P., Meena RV., Gupta V., et al., Ninety days of repeated gavage administration of Rhodiola extract in rats, J Appl Toxicology, 2011, 10, 1009–1015
- 15.Petkov VD., Yonkov D., Mosharoff A., Kambourova T., Alova L., Petkov VV., et al, Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory, Acta Physiol Pharmacol Bulg, 1986, 12, 3–16
- 16.Huang SC., Lee FT., Kuo TY., Yang JH., Chien CT., Attenuation of long-term Rhodiola rosea supplementation on exhaustive swimming evoked oxidative stress in the rat, Chin J Physiol, 2009, 52, 316–324
- 17.Brito GH., Davis BJ., Stopp LC., Stanton NE., Memory and septo-hippocampal cholinergic system in the rat, Psychopharmacology (Berlin), 1983, 81, 315–20
- 18.Falsafi SK., Deli A., Höger H., Pollak A., Lubec G., Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor system, PLoS ONE, 2012, 7, e32082
- 19.Wiedenfield H., Dumaa M., Malinowski M., Furmanowa M., Naratuya S., Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifolia, Pharmazie, 2007, 64, 308–11.
- 20.Edwards D., Heufelder A., Zimmermann A., Therapeutic effects and safety of Rhodiola rosea extract WS 1375 in subjects with life-stress symptoms-results of an open-label study, Phythother Res, 2012
|
|
|
|
|
|
|
|
|